Forced expression of DRAK1 in cervical cancer cells with acquired resistance to paclitaxel decreased cell growth and tumorigenesis of paclitaxel-resistant cells as well as cellular resistance to paclitaxel by downregulating TRAF6 expression and NF-κB activation. Here, STK17A is linked to cervical cancer.